Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 213

1.

Advances in the clinical science of the motor unit: from motor neuron to neuromuscular junction.

Talbot K, Vincent A.

Curr Opin Neurol. 2014 Oct;27(5):503-5. doi: 10.1097/WCO.0000000000000139. No abstract available.

PMID:
25159932
[PubMed - in process]
2.

Swallowing and oropharyngeal dysphagia.

Turner MR, Talbot K.

Clin Med. 2014 Aug;14(4):456. doi: 10.7861/clinmedicine.14-4-456a. No abstract available.

PMID:
25099863
[PubMed - in process]
3.

Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis.

Menke RA, Körner S, Filippini N, Douaud G, Knight S, Talbot K, Turner MR.

Brain. 2014 Sep;137(Pt 9):2546-55. doi: 10.1093/brain/awu162. Epub 2014 Jun 20.

PMID:
24951638
[PubMed - in process]
Free PMC Article
4.

Event- and time-triggered remembering: The impact of attention deficit hyperactivity disorder on prospective memory performance in children.

Talbot KD, Kerns KA.

J Exp Child Psychol. 2014 Nov;127:126-43. doi: 10.1016/j.jecp.2014.02.011. Epub 2014 Jun 3.

PMID:
24933706
[PubMed - in process]
5.

Autosomal dominant inheritance of rapidly progressive amyotrophic lateral sclerosis due to a truncation mutation in the fused in sarcoma (FUS) gene.

Kent L, Vizard TN, Smith BN, Topp SD, Vance C, Gkazi A, Miller J, Shaw CE, Talbot K.

Amyotroph Lateral Scler Frontotemporal Degener. 2014 Jun 5:1-6. [Epub ahead of print]

PMID:
24899262
[PubMed - as supplied by publisher]
6.

Newly identified precipitating factors in mechanical ventilation-induced brain damage: implications for treating ICU delirium.

González-López A, Albaiceta GM, Talbot K.

Expert Rev Neurother. 2014 Jun;14(6):583-8. doi: 10.1586/14737175.2014.915743.

PMID:
24852225
[PubMed - in process]
7.

FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion.

Bäumer D, East SZ, Tseu B, Zeman A, Hilton D, Talbot K, Ansorge O.

Acta Neuropathol. 2014 Oct;128(4):597-604. doi: 10.1007/s00401-014-1277-z. Epub 2014 Apr 10.

PMID:
24718895
[PubMed - in process]
8.

Mutations in the BLOC-1 Subunits Dysbindin and Muted Generate Divergent and Dosage-dependent Phenotypes.

Larimore J, Zlatic SA, Gokhale A, Tornieri K, Singleton KS, Mullin AP, Tang J, Talbot K, Faundez V.

J Biol Chem. 2014 May 16;289(20):14291-300. doi: 10.1074/jbc.M114.553750. Epub 2014 Apr 8.

PMID:
24713699
[PubMed - in process]
9.

A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories.

Akimoto C, Volk AE, van Blitterswijk M, Van den Broeck M, Leblond CS, Lumbroso S, Camu W, Neitzel B, Onodera O, van Rheenen W, Pinto S, Weber M, Smith B, Proven M, Talbot K, Keagle P, Chesi A, Ratti A, van der Zee J, Alstermark H, Birve A, Calini D, Nordin A, Tradowsky DC, Just W, Daoud H, Angerbauer S, DeJesus-Hernandez M, Konno T, Lloyd-Jani A, de Carvalho M, Mouzat K, Landers JE, Veldink JH, Silani V, Gitler AD, Shaw CE, Rouleau GA, van den Berg LH, Van Broeckhoven C, Rademakers R, Andersen PM, Kubisch C.

J Med Genet. 2014 Jun;51(6):419-24. doi: 10.1136/jmedgenet-2014-102360. Epub 2014 Apr 4.

PMID:
24706941
[PubMed - in process]
Free PMC Article
10.

Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs.

Talbot K.

Neurodegener Dis Manag. 2014 Feb;4(1):31-40. doi: 10.2217/nmt.13.73.

PMID:
24640977
[PubMed - in process]
11.

The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease.

Talbot K, Wang HY.

Alzheimers Dement. 2014 Feb;10(1 Suppl):S12-25. doi: 10.1016/j.jalz.2013.12.007.

PMID:
24529520
[PubMed - in process]
12.

T₂-weighted MRI detects presymptomatic pathology in the SOD1 mouse model of ALS.

Evans MC, Serres S, Khrapitchev AA, Stolp HB, Anthony DC, Talbot K, Turner MR, Sibson NR.

J Cereb Blood Flow Metab. 2014 May;34(5):785-93. doi: 10.1038/jcbfm.2014.19. Epub 2014 Feb 5.

PMID:
24496176
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning.

Glen WB Jr, Horowitz B, Carlson GC, Cannon TD, Talbot K, Jentsch JD, Lavin A.

Hippocampus. 2014 Feb;24(2):204-13. doi: 10.1002/hipo.22215. Epub 2013 Nov 12.

PMID:
24446171
[PubMed - in process]
14.

Advances in motor neurone disease.

Bäumer D, Talbot K, Turner MR.

J R Soc Med. 2014 Jan;107(1):14-21. doi: 10.1177/0141076813511451. Review.

PMID:
24399773
[PubMed - indexed for MEDLINE]
15.

Predictors of cognitive impairment in an early stage Parkinson's disease cohort.

Hu MT, Szewczyk-Królikowski K, Tomlinson P, Nithi K, Rolinski M, Murray C, Talbot K, Ebmeier KP, Mackay CE, Ben-Shlomo Y.

Mov Disord. 2014 Mar;29(3):351-9. doi: 10.1002/mds.25748. Epub 2014 Jan 6.

PMID:
24395708
[PubMed - in process]
Free Article
16.

Neuromuscular junction maturation defects precede impaired lower motor neuron connectivity in Charcot-Marie-Tooth type 2D mice.

Sleigh JN, Grice SJ, Burgess RW, Talbot K, Cader MZ.

Hum Mol Genet. 2014 May 15;23(10):2639-50. doi: 10.1093/hmg/ddt659. Epub 2013 Dec 23.

PMID:
24368416
[PubMed - in process]
17.

An eye-tracking version of the trail-making test.

Hicks SL, Sharma R, Khan AN, Berna CM, Waldecker A, Talbot K, Kennard C, Turner MR.

PLoS One. 2013 Dec 18;8(12):e84061. doi: 10.1371/journal.pone.0084061. eCollection 2013.

PMID:
24367626
[PubMed - in process]
Free PMC Article
18.

Expanding the genetics of huntingtonism.

Feigin A, Talbot K.

Neurology. 2014 Jan 28;82(4):286-7. doi: 10.1212/WNL.0000000000000067. Epub 2013 Dec 20. No abstract available.

PMID:
24363136
[PubMed - indexed for MEDLINE]
19.

Progressive hemiparesis (Mills syndrome) with aphasia in amyotrophic lateral sclerosis.

Bäumer D, Butterworth R, Menke RA, Talbot K, Hofer M, Turner MR.

Neurology. 2014 Feb 4;82(5):457-8. doi: 10.1212/WNL.0000000000000090. Epub 2013 Dec 20.

PMID:
24363135
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Overexpression of survival motor neuron improves neuromuscular function and motor neuron survival in mutant SOD1 mice.

Turner BJ, Alfazema N, Sheean RK, Sleigh JN, Davies KE, Horne MK, Talbot K.

Neurobiol Aging. 2014 Apr;35(4):906-15. doi: 10.1016/j.neurobiolaging.2013.09.030. Epub 2013 Oct 24.

PMID:
24210254
[PubMed - in process]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk